[go: up one dir, main page]

WO2021098436A1 - Visualized non-cell in vitro color development system, and preparation method therefor and use thereof - Google Patents

Visualized non-cell in vitro color development system, and preparation method therefor and use thereof Download PDF

Info

Publication number
WO2021098436A1
WO2021098436A1 PCT/CN2020/122343 CN2020122343W WO2021098436A1 WO 2021098436 A1 WO2021098436 A1 WO 2021098436A1 CN 2020122343 W CN2020122343 W CN 2020122343W WO 2021098436 A1 WO2021098436 A1 WO 2021098436A1
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
color
lysate
color development
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2020/122343
Other languages
French (fr)
Chinese (zh)
Inventor
王菊芳
孙秋丽
马毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Publication of WO2021098436A1 publication Critical patent/WO2021098436A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14Streptococcus; Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)

Definitions

  • the invention relates to the field of genetic engineering and synthetic biology detection, in particular to the establishment and application of a visual micro-acellular in vitro color-developing system.
  • the acellular expression system is an in vitro expression system based on cell lysates. It has been widely used in the synthesis of proteins that are difficult to express in the body, such as membrane proteins, toxic proteins, and in vitro genetic network research (Jessica G. Perez ,Jessica C.Stark, and Michael C.Jewett.Cell-Free Synthetic Biology: EngineeringBeyond the Cell[J]Cold Spring HarbPerspect Biol.2016; 1:8(12)).
  • prokaryotic and eukaryotic have been developed. Prokaryotic expression systems, especially E. coli expression systems, have always been favored due to their high yield, good stability and low cost.
  • E. coli lysate contains the most basic materials required for gene expression.
  • the transcription of genes in this system is generally regulated by exogenously added T7 RNA polymerase.
  • exogenous substrates required for protein synthesis such as amino acids, NTP and energy substances.
  • the non-cellular expression system commonly used in laboratories involves the composition of multiple energy systems (Kim DM, Swartz JR.
  • each energy system composition has its own advantages and disadvantages, such as phosphoenolpyruvate system provides more energy Fast, high protein yield, but expensive; sodium pyruvate energy system is cheap, but protein yield is relatively low.
  • a method for preparing a visual acellular in vitro color-developing system includes the following steps:
  • a color-developing system is prepared, including an engineered bacteria lysate, an energy supply system, an amino acid mixture and other substrate mixtures required for protein synthesis; the energy supply system contains phosphoenolpyruvate.
  • the concentration of the energy supply system is 20-28 mM; the concentration of the amino acid mixture is 40-60 mM.
  • the E. coli strain is BL21(DE3); the engineered bacteria lysate is a BL21(DE3) lysate that knocks out the ⁇ -galactosidase gene, that is, BL21(DE3) ⁇ lacZ lysate.
  • the amino acid mixture (containing 20 amino acids) is made of leucine, methionine, valine, lysine, phenylalanine, tryptophan, threonine, glycine, and arginine.
  • Acid, histidine, alanine, aspartic acid, asparagine, isoleucine, proline, tyrosine, serine, cysteine, glutamic acid and glutamine are prepared by adding water The mixture of equimolar concentration.
  • the substrate mixture required for the synthesis of other proteins is magnesium acetate, potassium glutamate, ammonium acetate, HEPES-KOH, tRNA, folic acid, dithiothreitol, putrescine, spermidine, oxalic acid, ATP, CTP, UTP, GTP, PEG8000, RNase inhibitor and chlorophenol red- ⁇ -D-galactopyranoside.
  • trehalose or polyvinyl alcohol is added as a protective agent in the color development system, the concentration of trehalose is 0.2-0.6M, and the concentration of polyvinyl alcohol is 5%-10%.
  • the application of the visualized non-cellular in vitro chromogenic system in the detection of pathogenic microorganisms specifically, a Toehold-Switch element plasmid for the detection target of pathogenic microorganisms is designed, and the 5'end of the plasmid contains a specific binding sequence with the detection target.
  • The'end contains the ⁇ -galactosidase gene; the above plasmid and the sample to be tested are added to the non-cellular in vitro color development system, and the reaction is allowed to stand still.
  • the color development is used to determine the presence or absence of the detection target in the system. When it is yellow, There is no corresponding detection target in the system. When it appears purple, the system has a corresponding detection target.
  • the reaction temperature is 30 ⁇ 5°C
  • the standing time is 20-60 min.
  • the establishment of a visual acellular color system includes the following steps:
  • the Red recombination method was used to knock out the ⁇ -galactosidase gene in Escherichia coli BL21(DE3) to obtain BL21(DE3) ⁇ lacZ engineering bacteria.
  • a 15 ⁇ L system was prepared, containing the engineered bacteria BL21(DE3) ⁇ lacZ lysate, energy supply system, amino acid mixture and reaction buffer; the system was allowed to stand at 30°C for 20min to react for expression and color development.
  • the Toehold-Switch element is a homologous RNA pair that regulates the target protein or biological activity by regulating the patent or translation process. It consists of two RNA chains called the switch and the trigger, called the Switch chain and the Trigger chain, respectively.
  • Switch RNA contains the coding sequence of the regulated gene. The upstream of the coding sequence contains a strong ribosome binding site (RBS) and start codon (AUG) based hairpin processing module, and then the coding is added to A common 21 nt linking sequence of low molecular weight amino acids at the N-terminus of the target protein gene. The single-stranded leader sequence at the 5'end of the hairpin module provides the initial binding site of the Trigger RNA strand.
  • the Trigger RNA contains an extended single-stranded region, which completes the process of branching and migration with the hairpin to expose the RBS and the initiation codon, thereby starting the translation and expression of the target protein gene.
  • the non-cellular chromogenic system of the present invention is used with Toehold-Switch element, the 5'end part of the element contains the specific binding sequence with the detection target, and the 3'end contains the ⁇ -galactosidase gene. If there is a detection target in the test sample, the element binds to the detection target and can successfully express ⁇ -galactosidase, then the system appears purple; on the contrary, if there is no corresponding detection target, the system appears yellow.
  • chromogenic system with Toehold-Switch components for rapid detection of pathogenic microorganisms, such as Norovirus type GII.4, Norovirus type GII.17, human coronavirus, Zika virus and Staphylococcus aureus, etc.
  • pathogenic microorganisms such as Norovirus type GII.4, Norovirus type GII.17, human coronavirus, Zika virus and Staphylococcus aureus, etc.
  • pathogenic microorganisms such as Norovirus type GII.4, Norovirus type GII.17, human coronavirus, Zika virus and Staphylococcus aureus, etc.
  • pathogenic microorganisms such as Norovirus type GII.4, Norovirus type GII.17, human coronavirus, Zika virus and Staphylococcus aureus, etc.
  • the advantages of the present invention are: simple operation, short time-consuming, low cost, miniaturization (10-15 ⁇ L), and the reaction situation can be observed by naked eyes; the color-developing system can be added with a protective agent under corresponding storage conditions Extend the storage time. It provides convenience for its application; the color development system can realize the judgment of the reaction situation by observing the color change by naked eyes, and can be widely used in the detection of pathogenic microorganisms.
  • Figure 1 is a graph showing the growth curve of BL21(DE3) ⁇ lacZ engineering bacteria in Example 2.
  • Figure 2 is an optimized diagram of the components of the non-cellular color rendering system in Example 3; A is an optimized diagram of T7 RNA polymerase, and B is an optimized diagram of an energy composition system.
  • Figure 3 is an expression diagram of the pET28a-lacZ plasmid in Example 3 in a micro-acellular color-developing system.
  • Figure 4 shows the results of the non-cellular color-developing system in Example 4 under different protective agents and storage conditions; A is the results of the protective agent trehalose and polyvinyl alcohol under 4°C storage conditions, and B is the protective agent trehalose And polyvinyl alcohol storage conditions at -20°C.
  • Figure 5 is a graph showing the detection results of the non-cellular color-developing system in Example 5 in GII.4-NoV, GII.17-NoV, HCoV and Zika; A is a graph showing the cross-detection results of 4 pathogenic microorganisms, and B is a graph of 4 pathogenic microorganisms. Cross detection color chart.
  • Fig. 6 is a graph showing the detection result of the non-cellular system in Example 5 in Staphylococcus aureus.
  • the pKD46 plasmid is chemically transformed into the BL21(DE3) strain to be knocked out.
  • the homology arm fragment containing the kana antibiotic gene recovered above was introduced into E. coli BL21(DE3)/pKD46 by electrotransformation.
  • the electrotransformation parameters are as follows: electrotransformation equipment: eppendorf2510; electrotransformation voltage: 2.0KV , 4ms.
  • Example 3 Establishment and verification of a cell-free coloring system
  • the E. coli ⁇ -galactosidase (lacZ) gene was amplified by PCR, and then connected to the expression vector pET28a (preserved in the laboratory) to construct a recombinant expression plasmid that can successfully express ⁇ -galactosidase.
  • lacZ lacZ
  • the specific construction method is as follows:
  • the BL21(DE3) ⁇ lacZ engineering bacteria itself can produce T7RNA polymerase after being induced by IPTG. Since T7RNA polymerase is indispensable in the color-developing system, it is guessed whether the addition of T7RNA polymerase can improve the rapid and large-scale expression of the color-developing system. , To achieve a better color rendering effect. It was experimentally verified that when T7 RNA polymerase (purchased from NEB, #M0251S) was additionally added, the expression level of the reaction system decreased instead, and the result is shown in Figure 2A. Therefore, the color-developing system does not require additional T7 RNA polymerase.
  • composition of mixture A is shown in Table 2:
  • the non-cellular color-developing system contains a variety of enzyme components. After being placed at 4°C or -20°C for 1 week, the activity decreases significantly.
  • trehalose As a new type of biomolecular protective agent, trehalose has been extensively studied and is often used as a protein stabilizer; there are also reports in the literature that polyvinyl alcohol is often used as an additive to maintain the activity of enzymes in the reaction system.
  • trehalose purchased from Beijing Probosin Biotechnology Co., Ltd., CAS#99-20-7
  • PVA polyvinyl alcohol
  • the stabilization effect of adding trehalose to the system is better than that of polyvinyl alcohol; but at -20°C Under storage conditions, the stabilizing effect of adding polyvinyl alcohol to the system is better than that of trehalose. Therefore, according to different storage conditions, different protective agents can be selected to extend the storage time of the system.
  • This embodiment is applied to the Toehold-Switch switch for RNA detection.
  • the detection target is Norovirus type GII.4.
  • the Toehold-Switch element is designed for this target, combined with the non-cellular color-developing system, and the presence of the detection target is judged by the change of the system color. happening.
  • the color system determines the presence or absence of the detection target in the system by color development. Prepare a cell-free coloring system according to Tables 1 and 2.
  • the plasmid is the Toehold-Switch element plasmid for each detection target. After interacting with Trigger plasmids of different targets at 30°C for 1 hour, observe the color change of the system and determine the OD570. The results are as follows Shown in Figure 5.
  • this embodiment combines the Toehold-Switch switch, the detection target is Staphylococcus aureus, the Toehold-Switch element is designed for this target, combined with the non-cellular color-developing system, and the existence of the detection target is judged by the color change of the system.
  • the Toehold-Switch elements for Staphylococcus aureus, Listeria monocytogenes, Salmonella and Vibrio parahaemolyticus, etc. obtained by laboratory screening are applied to the above-mentioned non-cellular in vitro color development system, and the detection in the system is determined by color development. The presence or absence of goals.
  • the plasmid is the Toehold-Switch element plasmid for each detection target. After interacting with the Trigger plasmid of different targets at 30°C for 0.7h, observe the color change of the system and measure the OD570. The result As shown in Figure 6.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Provided are a visualized non-cell in vitro color development system, and a preparation method therefor and the use thereof. The preparation method comprises the following steps: (1) preparing engineering bacteria: knocking out beta-galactosidase genes in an Escherichia coli strain through a Red recombinant method to obtain the engineering bacteria; (2) preparing an engineering bacteria lysate: determining the growth curve of the engineering bacteria, and preparing the engineering bacteria lysate; and (3) compounding a color development system: compounding the color development system which comprises the engineering bacteria lysate, an energy supply system, an amino acid mixed solution and a substrate mixed solution which is necessary for the synthesis of other proteins, wherein the energy supply system contains phosphoenolpyruvate. The non-cell color development system can be applied to the quick detection of pathogenic microorganisms, and the reaction situation can be seen by the naked eye of a user.

Description

一种可视化的非细胞体外显色体系及其制备方法和应用A visual acellular in vitro color-developing system and its preparation method and application 技术领域Technical field

本发明涉及基因工程和合成生物学检测领域,具体涉及一种可视化的微量非细胞体外显色体系建立及应用。The invention relates to the field of genetic engineering and synthetic biology detection, in particular to the establishment and application of a visual micro-acellular in vitro color-developing system.

背景技术Background technique

非细胞表达体系是一种以细胞裂解液为基础的体外表达体系,一直被广泛应用于在体内较难表达的蛋白质的合成如膜蛋白、毒性蛋白,以及体外遗传网络的研究(Jessica G.Perez,Jessica C.Stark,and Michael C.Jewett.Cell-Free Synthetic Biology:EngineeringBeyond the Cell[J]Cold Spring HarbPerspect Biol.2016;1:8(12))。目前,已开发出原核和真核两大类非细胞表达系统,其中原核表达系统尤其是大肠杆菌表达系统,由于产率高、稳定性好和成本低的优势,一直备受青睐。The acellular expression system is an in vitro expression system based on cell lysates. It has been widely used in the synthesis of proteins that are difficult to express in the body, such as membrane proteins, toxic proteins, and in vitro genetic network research (Jessica G. Perez ,Jessica C.Stark, and Michael C.Jewett.Cell-Free Synthetic Biology: EngineeringBeyond the Cell[J]Cold Spring HarbPerspect Biol.2016; 1:8(12)). At present, two types of non-cellular expression systems, prokaryotic and eukaryotic have been developed. Prokaryotic expression systems, especially E. coli expression systems, have always been favored due to their high yield, good stability and low cost.

在大肠杆菌非细胞表达体系中,大肠杆菌裂解液含有基因表达所需的最基本的物质。该体系的基因的转录一般由外源添加的T7RNA聚合酶调控,此外还需外源添加氨基酸、NTP及能量物质等蛋白质合成所需的底物。实验室常用的非细胞表达体系中涉及多种能量体系的组成(Kim DM,Swartz JR.Regeneration of adenosine triphosphate from glycolytic intermediates for cell-free protein synthesis[J]BiotechnolBioeng.2001;74(4):309-16.),如丙酮酸钠/CoA/NAD,PEP/PK,CP/CK,cAMP/CP/CK,每种能量体系组成各有其优势和劣势,比如磷酸烯醇式丙酮酸体系提供能量较快,蛋白产量高,但价格昂贵;丙酮酸钠能量体系价格便宜,但蛋白产量相对较低。In the E. coli non-cellular expression system, E. coli lysate contains the most basic materials required for gene expression. The transcription of genes in this system is generally regulated by exogenously added T7 RNA polymerase. In addition, it is also necessary to add exogenous substrates required for protein synthesis such as amino acids, NTP and energy substances. The non-cellular expression system commonly used in laboratories involves the composition of multiple energy systems (Kim DM, Swartz JR. Regeneration of adenosine triphosphate from glycolytic intermediates for cell-free protein synthesis[J]BiotechnolBioeng.2001;74(4):309- 16.), such as sodium pyruvate/CoA/NAD, PEP/PK, CP/CK, cAMP/CP/CK, each energy system composition has its own advantages and disadvantages, such as phosphoenolpyruvate system provides more energy Fast, high protein yield, but expensive; sodium pyruvate energy system is cheap, but protein yield is relatively low.

目前关于病原微生物检测方法多种多样(Mangal M,Bansal S,Sharma SK,et al.Molecular Detection of Foodborne Pathogens:A Rapid and Accurate Answer to Food Safety[J]Crit Rev Food Sci Nutr.2016;56(9):1568-84.),比如常见的培养法,RT-PCR,分子信标法,胶体金法等,但是这些检测方法需要昂贵的仪器和设备,技巧性极强,并且需要专业的操作人员,不具有简单、快速、易于便携的特点, 因此在偏远地区以及缺乏专业技术人员的现场很难通过这些手段进行检测。综上,开发简单、快速,无需昂贵仪器的检测方法迫在眉睫。At present, there are various detection methods for pathogenic microorganisms (Mangal M, Bansal S, Sharma SK, et al. Molecular Detection of Foodborne Pathogens: A Rapid and Accurate Answer to Food Safety[J] Crit Rev Food Sci Nutr. 2016; 56(9 ):1568-84.), such as common culture methods, RT-PCR, molecular beacon method, colloidal gold method, etc., but these detection methods require expensive instruments and equipment, extremely skilled, and require professional operators , Does not have the characteristics of simplicity, speed, and portability, so it is difficult to detect by these means in remote areas and on-site where there is a lack of professional and technical personnel. In summary, it is imminent to develop simple and fast detection methods that do not require expensive equipment.

发明内容Summary of the invention

针对上述问题,我们建立一种依赖于β-半乳糖苷酶水解底物的显色表达体系,首先,敲除大肠杆菌自身β-半乳糖苷酶基因消除背景干扰;接着,优化非细胞体系的组成成分,提高非细胞体系的表达效率。本发明的主要目的在于建立一种简单、快速、可视化的微量非细胞显色体系。In response to the above problems, we established a chromogenic expression system that relies on β-galactosidase to hydrolyze the substrate. First, knock out E. coli’s own β-galactosidase gene to eliminate background interference; then, optimize the non-cellular system The composition improves the expression efficiency of the non-cellular system. The main purpose of the present invention is to establish a simple, fast and visualized micro-acellular color development system.

本发明的技术方案如下:The technical scheme of the present invention is as follows:

一种可视化的非细胞体外显色体系的制备方法,包括如下步骤:A method for preparing a visual acellular in vitro color-developing system includes the following steps:

(1)工程菌的制备:(1) Preparation of engineering bacteria:

利用Red重组法敲除大肠杆菌菌株中β-半乳糖苷酶基因,获得工程菌;Using Red recombination method to knock out the β-galactosidase gene in E. coli strains to obtain engineered bacteria;

(2)工程菌裂解液的制备:(2) Preparation of engineered bacteria lysate:

测定上述工程菌的生长曲线,制备工程菌裂解液;Determine the growth curve of the above-mentioned engineered bacteria, and prepare the engineered bacteria lysate;

(3)显色体系的配制:(3) Preparation of color rendering system:

配制显色体系,包括工程菌裂解液、能量供应体系、氨基酸混合液和其他蛋白质合成所需的底物混合液;所述能量供应体系含磷酸烯醇式丙酮酸。A color-developing system is prepared, including an engineered bacteria lysate, an energy supply system, an amino acid mixture and other substrate mixtures required for protein synthesis; the energy supply system contains phosphoenolpyruvate.

优选地,所述能量供应体系的浓度为20~28mM;所述氨基酸混合液的浓度为40~60mM。Preferably, the concentration of the energy supply system is 20-28 mM; the concentration of the amino acid mixture is 40-60 mM.

优选地,所述大肠杆菌菌株为BL21(DE3);所述工程菌裂解液为敲除β-半乳糖苷酶基因的BL21(DE3)裂解液,即BL21(DE3)ΔlacZ裂解液。Preferably, the E. coli strain is BL21(DE3); the engineered bacteria lysate is a BL21(DE3) lysate that knocks out the β-galactosidase gene, that is, BL21(DE3) ΔlacZ lysate.

优选地,所述氨基酸混合液(含20种氨基酸)为用亮氨酸、甲硫氨酸、缬氨酸、赖氨酸、苯丙氨酸、色氨酸、苏氨酸、甘氨酸、精氨酸、组氨酸、丙氨酸、天冬氨酸、天冬酰胺、异亮氨酸、脯氨酸、酪氨酸、丝氨酸、半胱氨酸、谷氨酸和谷氨酰胺加入水配成的等摩尔浓度的混合液。Preferably, the amino acid mixture (containing 20 amino acids) is made of leucine, methionine, valine, lysine, phenylalanine, tryptophan, threonine, glycine, and arginine. Acid, histidine, alanine, aspartic acid, asparagine, isoleucine, proline, tyrosine, serine, cysteine, glutamic acid and glutamine are prepared by adding water The mixture of equimolar concentration.

优选地,所述其他蛋白质合成所需的底物混合液为醋酸镁、谷氨酸钾、醋酸铵、HEPES-KOH、tRNA、叶酸、二硫苏糖醇、腐胺、亚精胺、草酸、ATP、CTP、UTP、GTP、PEG8000、RNA酶抑制剂和氯酚红-β-D-半乳吡喃糖苷。Preferably, the substrate mixture required for the synthesis of other proteins is magnesium acetate, potassium glutamate, ammonium acetate, HEPES-KOH, tRNA, folic acid, dithiothreitol, putrescine, spermidine, oxalic acid, ATP, CTP, UTP, GTP, PEG8000, RNase inhibitor and chlorophenol red-β-D-galactopyranoside.

优选地,所述显色体系中还添加海藻糖或聚乙烯醇作为保护剂,海藻糖的浓度为0.2~0.6M,聚乙烯醇的浓度为5%~10%。Preferably, trehalose or polyvinyl alcohol is added as a protective agent in the color development system, the concentration of trehalose is 0.2-0.6M, and the concentration of polyvinyl alcohol is 5%-10%.

所述的可视化的非细胞体外显色体系在病原微生物检测中的应用,具体地,设计针对病原微生物检测靶标的Toehold-Switch元件质粒,该质粒5’端部分含有与检测靶标特异结合序列,3’端含有β-半乳糖苷酶基因;将上述质粒和待检样品加入非细胞体外显色体系中,静置反应,通过显色情况来判定体系中检测目标的有无,当呈现黄色时,体系不存在相应检测靶标,当呈现紫色时,体系存在相应检测靶标。The application of the visualized non-cellular in vitro chromogenic system in the detection of pathogenic microorganisms, specifically, a Toehold-Switch element plasmid for the detection target of pathogenic microorganisms is designed, and the 5'end of the plasmid contains a specific binding sequence with the detection target. The'end contains the β-galactosidase gene; the above plasmid and the sample to be tested are added to the non-cellular in vitro color development system, and the reaction is allowed to stand still. The color development is used to determine the presence or absence of the detection target in the system. When it is yellow, There is no corresponding detection target in the system. When it appears purple, the system has a corresponding detection target.

优选地,所述反应温度为30±5℃,静置时间为20~60min。Preferably, the reaction temperature is 30±5°C, and the standing time is 20-60 min.

一种可视化的非细胞显色体系建立,包括如下步骤:The establishment of a visual acellular color system includes the following steps:

(1)大肠杆菌BL21(DE3)ΔlacZ工程菌的构建(1) Construction of Escherichia coli BL21(DE3)ΔlacZ engineering bacteria

利用Red重组方法敲除大肠杆菌BL21(DE3)中β-半乳糖苷酶基因获得BL21(DE3)ΔlacZ工程菌。The Red recombination method was used to knock out the β-galactosidase gene in Escherichia coli BL21(DE3) to obtain BL21(DE3)ΔlacZ engineering bacteria.

(2)工程菌BL21(DE3)ΔlacZ裂解液的制备(2) Preparation of engineering bacteria BL21(DE3)ΔlacZ lysate

测定BL21(DE3)ΔlacZ工程菌的生长曲线。根据生长曲线,在OD为0.4~0.6时进行IPTG诱导,待菌生长到OD为3.5~4.0时收集菌体。用S30缓冲液洗涤3次,高压破碎仪20kpsi破碎2次,12,000g,30min后取上清,即为工程菌BL21(DE3)ΔlacZ的裂解液。Determine the growth curve of BL21(DE3)ΔlacZ engineering bacteria. According to the growth curve, IPTG induction is performed when the OD is 0.4-0.6, and the bacteria are collected when the OD is 3.5-4.0. Wash 3 times with S30 buffer, 2 times with high pressure disintegrator 20kpsi, 12,000g, 30min, take the supernatant, which is the lysate of engineering bacteria BL21(DE3)ΔlacZ.

(3)非细胞显色体系组成成分优化(3) Optimization of the composition of the non-cellular color rendering system

①外源添加T7RNA聚合酶的量的优化;① Optimization of the amount of T7 RNA polymerase added exogenously;

②能量体系组成的优化。②Optimization of the composition of the energy system.

(4)非细胞显色体系的可视化反应表达(4) Visual reaction expression of non-cellular color system

配制15μL体系,内含工程菌BL21(DE3)ΔlacZ裂解液、能量供应体系、氨基酸混合液和反应缓冲液;将体系在30℃,静置反应20min,用于表达显色。A 15μL system was prepared, containing the engineered bacteria BL21(DE3)ΔlacZ lysate, energy supply system, amino acid mixture and reaction buffer; the system was allowed to stand at 30°C for 20min to react for expression and color development.

(5)非细胞显色体系的稳定性优化(5) Optimization of the stability of the non-cellular color system

根据保存温度条件,选择合适的外源保护剂,以提高非细胞显色体系的长期稳定性。According to the storage temperature conditions, select the appropriate exogenous protective agent to improve the long-term stability of the non-cellular color-developing system.

(6)非细胞显色体系在病原微生物检测中的应用(6) Application of acellular color system in the detection of pathogenic microorganisms

Toehold-Switch元件是通过调控专利或翻译过程从而调控目的蛋白或生物活性的同源RNA对,由两个称为开关和触发器的RNA链组成,分别称为Switch链和Trigger链。Switch RNA含有被调节基因的编码序列,该编码序列的上游包含 有较强的核糖体结合位点(RBS)和起始密码子(AUG)的基于发夹的加工模块,其后是编码添加到目的蛋白基因的N末端的低分子量氨基酸的共同21nt的连接序列。该发夹模块的5’末端的单链前导序列提供Trigger RNA链的初始结合位点。该Trigger RNA含有延伸的单链区域,其完成与发夹的分支迁移过程以暴露RBS和起始密码子,由此启动目的蛋白基因的翻译表达。The Toehold-Switch element is a homologous RNA pair that regulates the target protein or biological activity by regulating the patent or translation process. It consists of two RNA chains called the switch and the trigger, called the Switch chain and the Trigger chain, respectively. Switch RNA contains the coding sequence of the regulated gene. The upstream of the coding sequence contains a strong ribosome binding site (RBS) and start codon (AUG) based hairpin processing module, and then the coding is added to A common 21 nt linking sequence of low molecular weight amino acids at the N-terminus of the target protein gene. The single-stranded leader sequence at the 5'end of the hairpin module provides the initial binding site of the Trigger RNA strand. The Trigger RNA contains an extended single-stranded region, which completes the process of branching and migration with the hairpin to expose the RBS and the initiation codon, thereby starting the translation and expression of the target protein gene.

本发明非细胞显色体系应用时搭配Toehold-Switch元件,该元件5’端部分含有与检测靶标特异结合序列,3’端含有β-半乳糖苷酶基因。若检测样本中存在检测靶标时,该元件与检测靶标结合,可成功表达β-半乳糖苷酶,此时该体系呈现紫色;相反,若不存在相应检测靶标时,该体系呈现黄色。将该显色体系结合Toehold-Switch元件应用于病原微生物的快速检测,如GII.4型诺如病毒,GII.17型诺如病毒,人冠状病毒,寨卡病毒和金黄色葡萄球菌等的检测中,当体系中出现检测目标时,体系颜色由浅黄色变为紫色,肉眼即可判断检测目标的有无,并确定其特异性。本发明非细胞显色体系的应用不限于上述几种病原微生物,只要设计了对应的Toehold-Switch元件,病原微生物都可以被检测出来。The non-cellular chromogenic system of the present invention is used with Toehold-Switch element, the 5'end part of the element contains the specific binding sequence with the detection target, and the 3'end contains the β-galactosidase gene. If there is a detection target in the test sample, the element binds to the detection target and can successfully express β-galactosidase, then the system appears purple; on the contrary, if there is no corresponding detection target, the system appears yellow. Combining the chromogenic system with Toehold-Switch components for rapid detection of pathogenic microorganisms, such as Norovirus type GII.4, Norovirus type GII.17, human coronavirus, Zika virus and Staphylococcus aureus, etc. When the detection target appears in the system, the color of the system changes from light yellow to purple, and the naked eye can judge the presence or absence of the detection target and determine its specificity. The application of the non-cellular chromogenic system of the present invention is not limited to the above-mentioned several pathogenic microorganisms. As long as the corresponding Toehold-Switch element is designed, the pathogenic microorganisms can be detected.

本发明的优点是:操作简便,耗时短,低成本,微量化(10~15μL)并可肉眼观察反应情况;所述显色体系可在添加保护剂的情况下,在相应的保存条件下延长保存时间。为其应用提供便利;所述显色体系可实现通过肉眼观察颜色变化判断反应情况,可在病原微生物检测方面得到广泛应用。The advantages of the present invention are: simple operation, short time-consuming, low cost, miniaturization (10-15 μL), and the reaction situation can be observed by naked eyes; the color-developing system can be added with a protective agent under corresponding storage conditions Extend the storage time. It provides convenience for its application; the color development system can realize the judgment of the reaction situation by observing the color change by naked eyes, and can be widely used in the detection of pathogenic microorganisms.

附图说明Description of the drawings

图1为实施例2中BL21(DE3)ΔlacZ工程菌的生长曲线图。Figure 1 is a graph showing the growth curve of BL21(DE3)ΔlacZ engineering bacteria in Example 2.

图2为实施例3中非细胞显色体系组分优化图;A为T7RNA聚合酶优化图,B为能量组成体系优化图。Figure 2 is an optimized diagram of the components of the non-cellular color rendering system in Example 3; A is an optimized diagram of T7 RNA polymerase, and B is an optimized diagram of an energy composition system.

图3为实施例3中pET28a-lacZ质粒在微量非细胞显色体系中的表达图。Figure 3 is an expression diagram of the pET28a-lacZ plasmid in Example 3 in a micro-acellular color-developing system.

图4为实施例4中非细胞显色体系在不同保护剂和保存条件下的结果图;A为保护剂海藻糖和聚乙烯醇在4℃保存条件下的结果图,B为保护剂海藻糖和聚乙烯醇在-20℃保存条件下的结果图。Figure 4 shows the results of the non-cellular color-developing system in Example 4 under different protective agents and storage conditions; A is the results of the protective agent trehalose and polyvinyl alcohol under 4℃ storage conditions, and B is the protective agent trehalose And polyvinyl alcohol storage conditions at -20°C.

图5为实施例5中非细胞显色体系在GII.4-NoV,GII.17-NoV,HCoV和Zika的检测结果图;A为4种病原微生物交叉检测结果图,B为4种病原微生物交叉检测显色图。Figure 5 is a graph showing the detection results of the non-cellular color-developing system in Example 5 in GII.4-NoV, GII.17-NoV, HCoV and Zika; A is a graph showing the cross-detection results of 4 pathogenic microorganisms, and B is a graph of 4 pathogenic microorganisms. Cross detection color chart.

图6为实施例5中非细胞体系在金黄色葡萄球菌中的检测结果图。Fig. 6 is a graph showing the detection result of the non-cellular system in Example 5 in Staphylococcus aureus.

具体实施方式Detailed ways

为了更好的理解上述技术方案,下面结合说明书附图以及具体的实施方式随上述技术方案进行详细的说明。In order to better understand the above-mentioned technical solution, the following detailed description will be given with the above-mentioned technical solution in conjunction with the drawings and specific implementations of the specification.

实施例1大肠杆菌BL21(DE3)ΔlacZ工程菌的构建。Example 1 Construction of Escherichia coli BL21(DE3) ΔlacZ engineering bacteria.

1.根据敲除靶基因序列设计同源臂序列:1. Design the homology arm sequence according to the knockout target gene sequence:

Figure PCTCN2020122343-appb-000001
Figure PCTCN2020122343-appb-000001

2.以pKD4质粒为模板,用上述同源臂引物进行卡那抗性基因的扩增,具体步骤如下:2. Using the pKD4 plasmid as a template, use the above homology arm primers to amplify the kana resistance gene. The specific steps are as follows:

(1)PCR反应体系(50μL):(1) PCR reaction system (50μL):

Figure PCTCN2020122343-appb-000002
Figure PCTCN2020122343-appb-000002

(2)PCR扩增反应程序(2) PCR amplification reaction program

Figure PCTCN2020122343-appb-000003
Figure PCTCN2020122343-appb-000003

(3)PCR反应结束后,1%(w/v)琼脂糖凝胶电泳鉴定,得到大小约为1.6kb的包含linker序列的基因片段,对PCR产物进行纯化回收,得到含有卡那抗生素基因的同源臂片段,置于-20℃保存待用(3) After the PCR reaction is completed, 1% (w/v) agarose gel electrophoresis is identified, and a gene fragment containing the linker sequence with a size of about 1.6 kb is obtained. The PCR product is purified and recovered to obtain a kana antibiotic gene. Homologous arm fragment, stored at -20℃ for later use

3.利用Red同源重组的原理与方法敲除BL21(DE3)(购买于天根生化科技有限公司)的lacZ基因,具体敲除方法如下:3. Using the principle and method of Red homologous recombination to knock out the lacZ gene of BL21(DE3) (purchased from Tiangen Biochemical Technology Co., Ltd.), the specific knockout method is as follows:

(1)将pKD46质粒化学转化入待敲除的BL21(DE3)菌株中。(1) The pKD46 plasmid is chemically transformed into the BL21(DE3) strain to be knocked out.

(2)将上述回收得到的含有卡那抗生素基因的同源臂片段通过电转化的方法导入进大肠杆菌BL21(DE3)/pKD46,电转化参数如下:电转化设备:eppendorf2510;电转电压:2.0KV,4ms。(2) The homology arm fragment containing the kana antibiotic gene recovered above was introduced into E. coli BL21(DE3)/pKD46 by electrotransformation. The electrotransformation parameters are as follows: electrotransformation equipment: eppendorf2510; electrotransformation voltage: 2.0KV , 4ms.

(3)添加了终浓度为50μg/mL的卡那霉素抗性的LB平板进行筛选阳性克隆,并进行菌落PCR验证,将构建的突变株命名为BL21(DE3)ΔlacZ。(3) A kanamycin-resistant LB plate with a final concentration of 50 μg/mL was added to screen positive clones and verified by colony PCR. The constructed mutant was named BL21(DE3)ΔlacZ.

实施例2大肠杆菌BL21(DE3)ΔlacZ裂解液的制备Example 2 Preparation of E. coli BL21 (DE3) ΔlacZ lysate

1.大肠杆菌BL21(DE3)ΔlacZ工程菌生长曲线的测定:1. Determination of the growth curve of Escherichia coli BL21(DE3)ΔlacZ engineering bacteria:

(1)从平板上挑取上述构建的BL21(DE3)ΔlacZ单菌落接种于5mL LB培养基中,37℃摇床220rpm培养过夜。(1) Pick the single colony of BL21(DE3)ΔlacZ constructed above from the plate and inoculate it in 5mL LB medium, and cultivate overnight at 37°C in a shaker at 220 rpm.

(2)将种子液以1:100分别转接至2瓶300mL的2×YTPG培养基中,继续37℃摇床220rpm培养。(2) Transfer the seed solution to 2 bottles of 300 mL of 2×YTPG medium at a ratio of 1:100, and continue culturing on a shaker at 37°C at 220 rpm.

(3)1h后取样测定OD600,之后每半小时取样1次检测OD600,3次重复并记录。(3) Sampling and measuring OD600 after 1 hour, and then sampling once every half an hour to detect OD600, repeat 3 times and record.

(4)当OD600在0.4~0.6时往1瓶培养基中添加1mM异丙基硫代半乳糖苷(IPTG)进行诱导,与对照组一起每隔半小时取样测定OD600,3次重复并记录。(4) When the OD600 is between 0.4 and 0.6, add 1 mM isopropyl thiogalactoside (IPTG) to a bottle of culture medium for induction, take samples every half an hour together with the control group to determine OD600, repeat and record 3 times.

(5)根据数据作图BL21(DE3)ΔlacZ工程菌的生长曲线,如图1所示。(5) Plot the growth curve of the BL21(DE3)ΔlacZ engineering bacteria based on the data, as shown in Figure 1.

2.大肠杆菌BL21(DE3)ΔlacZ裂解液的制备:2. Preparation of E. coli BL21(DE3)ΔlacZ lysate:

(1)从平板上挑取上述构建的BL21(DE3)ΔlacZ单菌落接种于5mL LB培养基中,37℃摇床220rpm培养过夜。(1) Pick the single colony of BL21(DE3)ΔlacZ constructed above from the plate and inoculate it in 5mL LB medium, and cultivate overnight at 37°C in a shaker at 220 rpm.

(2)将种子液以1:100转接至300mL的2×YTPG培养基中,继续37℃摇床220rpm培养。(2) Transfer the seed solution to 300 mL of 2×YTPG medium at a ratio of 1:100, and continue culturing in a shaker at 37°C at 220 rpm.

(3)按照1中所测定的生长曲线,当培养约2h,至菌浓度OD600值为0.4~0.6 时,加入1mM IPTG进行诱导,继续培养。当菌浓度OD600值达到3.5~4时开始收集菌体。(3) According to the growth curve determined in 1, when cultured for about 2 hours and the bacterial concentration OD600 is 0.4-0.6, add 1mM IPTG for induction and continue the culture. When the OD600 value of the bacterial concentration reaches 3.5 to 4, the bacterial cells are collected.

(4)用预冷的S30Buffer(10mM Tris(pH8.2),14mM醋酸镁,60mM谷氨酸钾,2mM二硫苏糖醇)重悬菌体,振荡器充分混匀,4℃,8000g离心7min,倒去上清。此步骤重复3次。(4) Resuspend the bacteria in pre-chilled S30Buffer (10mM Tris (pH8.2), 14mM magnesium acetate, 60mM potassium glutamate, 2mM dithiothreitol), mix thoroughly with a shaker, and centrifuge at 4°C at 8000g 7min, pour the supernatant. Repeat this step 3 times.

(5)每1g菌体加入1mL预冷S30Buffer,充分混匀。(5) Add 1mL of pre-cooled S30Buffer per 1g of bacteria and mix well.

(6)用高压细胞破碎仪20kpsi破碎细胞2次。将破胞液4℃,12,000g离心20min,取上清。(6) Crush the cells twice with a high-pressure cell disruptor at 20 kpsi. Centrifuge the lysate at 12,000g for 20min at 4°C, and take the supernatant.

(7)4℃,12,000g再次离心20min,取上清,即为裂解液。分装上清于0.5mL EP管中,每管50μL,液氮速冻后放入-80℃冰箱保存。(7) Centrifuge again at 12,000g for 20 minutes at 4°C, and take the supernatant, which is the lysate. Aliquot the supernatant into 0.5mL EP tubes, 50μL per tube, quick-frozen in liquid nitrogen, and store in the refrigerator at -80℃.

实施例3非细胞显色体系建立及验证Example 3 Establishment and verification of a cell-free coloring system

1.pET28a-lacZ载体构建:1. pET28a-lacZ vector construction:

PCR扩增大肠杆菌β-半乳糖苷酶(lacZ)基因,然后连接至表达载体pET28a(实验室保存)中,构建可成功表达β-半乳糖苷酶的重组表达质粒。具体构建方法如下:The E. coli β-galactosidase (lacZ) gene was amplified by PCR, and then connected to the expression vector pET28a (preserved in the laboratory) to construct a recombinant expression plasmid that can successfully express β-galactosidase. The specific construction method is as follows:

(1)设计扩增lacZ基因的引物:(1) Design primers for amplification of lacZ gene:

Figure PCTCN2020122343-appb-000004
Figure PCTCN2020122343-appb-000004

(2)PCR反应体系(50μL):(2) PCR reaction system (50μL):

Figure PCTCN2020122343-appb-000005
Figure PCTCN2020122343-appb-000005

(3)PCR扩增反应程序:(3) PCR amplification reaction program:

Figure PCTCN2020122343-appb-000006
Figure PCTCN2020122343-appb-000006

Figure PCTCN2020122343-appb-000007
Figure PCTCN2020122343-appb-000007

PCR反应结束后,1%(w/v)琼脂糖凝胶电泳鉴定,切胶回收3100bp左右的目的片段。After the PCR reaction was completed, 1% (w/v) agarose gel electrophoresis was used for identification, and the gel was cut to recover the target fragment of about 3100bp.

(4)将回收产物和pET28a质粒同时做BamHI/Hind III双酶切,酶切体系如下(50μL):(4) The recovered product and pET28a plasmid were subjected to BamHI/Hind III double digestion at the same time, and the digestion system was as follows (50μL):

Figure PCTCN2020122343-appb-000008
Figure PCTCN2020122343-appb-000008

置于37℃恒温PCR仪中反应3h。酶切反应完后,纯化回收。Place it in a constant temperature PCR instrument at 37°C to react for 3 hours. After the enzyme digestion reaction is completed, it is purified and recovered.

(5)将步骤(4)中得到的回收产物进行T4连接酶连接,具体操作如下:连接反应体系(20μL):(5) Connect the recovered product obtained in step (4) with T4 ligase, and the specific operation is as follows: connect the reaction system (20 μL):

Figure PCTCN2020122343-appb-000009
Figure PCTCN2020122343-appb-000009

置于16℃恒温PCR仪中反应12h。Placed in a 16°C constant temperature PCR machine to react for 12 hours.

(6)连接反应完毕后,将连接产物转化至大肠杆菌DH5α中,然后将菌液涂至含卡那青霉素(终浓度为50μg/mL)的LB固体平板中,置于37℃培养箱培养过夜。转化方法采用的是化学转化法。(6) After the ligation reaction is completed, transform the ligation product into Escherichia coli DH5α, and then apply the bacterial solution to the LB solid plate containing kanapenicillin (final concentration of 50μg/mL), and place it in a 37°C incubator overnight. . The conversion method uses a chemical conversion method.

(7)对平板中长出的单克隆进行测序鉴定。筛选出正确携带lacZ基因的质粒pET28a-lacZ。(7) Sequencing and identification of the single clones grown in the plate. The plasmid pET28a-lacZ which correctly carries the lacZ gene was screened out.

2.非细胞显色体系建立:2. Establishment of non-cellular color rendering system:

(1)体系组分的优化(1) Optimization of system components

BL21(DE3)ΔlacZ工程菌本身经IPTG诱导后可产生T7RNA聚合酶,由于T7RNA聚合酶在该显色体系中必不可少,因此猜想额外添加T7RNA聚合酶是否可以提高显色体系的快速及大量表达,达到更好的显色效果。经实验验证,额外添加T7RNA聚合酶(购于NEB,#M0251S),反应体系的表达量反而降低,结果如图2A所示。因此,该显色体系不需额外添加T7RNA聚合酶。The BL21(DE3)ΔlacZ engineering bacteria itself can produce T7RNA polymerase after being induced by IPTG. Since T7RNA polymerase is indispensable in the color-developing system, it is guessed whether the addition of T7RNA polymerase can improve the rapid and large-scale expression of the color-developing system. , To achieve a better color rendering effect. It was experimentally verified that when T7 RNA polymerase (purchased from NEB, #M0251S) was additionally added, the expression level of the reaction system decreased instead, and the result is shown in Figure 2A. Therefore, the color-developing system does not require additional T7 RNA polymerase.

非细胞体系中,可提供能量的体系组成有多种,我们选择了价廉的丙酮酸盐(Sodium pyruvate,SP)能量体系和快速提供ATP的磷酸烯醇式丙酮酸(PEP)能量体系。经实验比较发现,PEP的效果优于SP的效果,如图2B所示,原因可能是PEP可快速供能,使体系快速达到显色效果。In the non-cellular system, there are many system components that can provide energy. We chose the cheap pyruvate (SP) energy system and the phosphoenolpyruvate (PEP) energy system that quickly provides ATP. After comparing experiments, it is found that the effect of PEP is better than that of SP. As shown in Figure 2B, the reason may be that PEP can quickly supply energy, so that the system can quickly achieve the color rendering effect.

(2)体系组分的确立及可视化表达(2) The establishment and visual expression of system components

体系中各组分的用量见表1:The dosage of each component in the system is shown in Table 1:

试剂Reagent 使用浓度Use concentration 储存温度Storage temperature 混合液AMixture A  To -20℃-20℃ RNA酶抑制剂RNase inhibitor 0.27U/μL0.27U/μL -20℃-20℃ UTPUTP 0.86mM0.86mM -20℃-20℃ ATPATP 0.86mM0.86mM -20℃-20℃ GTPGTP 0.86mM0.86mM -20℃-20℃ CTPCTP 0.86mM0.86mM -20℃-20 PEG8000PEG8000 2%2% -20℃-20℃ PEPPEP 20mM20mM -20℃-20℃ 20种氨基酸混合液20 kinds of amino acid mixture 40~60mM40~60mM -20℃-20℃ 工程菌裂解液Engineering bacteria lysate 25%25% -80℃-80℃ CPRGCPRG 0.6mg/mL0.6mg/mL -20℃-20℃

混合液A的组成成分见表2:The composition of mixture A is shown in Table 2:

试剂Reagent 使用浓度Use concentration 储存温度Storage temperature 醋酸镁Magnesium acetate 12mM12mM -20℃-20℃ 谷氨酸钾Potassium Glutamate 90mM90mM -20℃-20℃ 醋酸铵Ammonium acetate 80mM80mM -20℃-20℃

HEPES-KOHHEPES-KOH 57mM57mM -20℃-20℃ DTTDTT 2mM2mM -20℃-20℃ 腐胺Putrescine 1mM1mM -20℃-20℃ 亚精胺Spermidine 1.5mM1.5mM -20℃-20℃ 草酸oxalic acid 4mM4mM -20℃-20℃ 亚叶酸Folinic acid 0.034mg/mL0.034mg/mL -20℃-20℃ tRNAtRNA 0.171mg/mL0.171mg/mL -20℃-20℃

按照表1和表2配制15μL反应体系,加入质粒pET28a-lacZ(13.3ng/μL),30℃,静置20min后观察颜色变化,并测定OD570值,结果如图3所示:在30℃静置20min后,反应体系颜色由浅黄色变为紫色。Prepare a 15μL reaction system according to Table 1 and Table 2, add plasmid pET28a-lacZ (13.3ng/μL), stand at 30°C for 20 minutes, observe the color change, and determine the OD570 value. The result is shown in Figure 3: static at 30°C After standing for 20 minutes, the color of the reaction system changed from light yellow to purple.

实施例4非细胞显色体系的稳定性探索Example 4 Exploration of the stability of the non-cellular color-developing system

非细胞显色体系中含有多种酶成分,在4℃或-20℃条件下放置1周后,活性明显下降。海藻糖作为一种新型的生物分子保护剂,得到了广泛的研究,常被用作蛋白质的稳定剂;也有文献报道聚乙烯醇常被用作添加剂来保持反应体系中酶的活性。为了提高显色体系的稳定性,研究了海藻糖(Trehalose)(购于北京普博欣生物技术有限公司,CAS#99-20-7)和聚乙烯醇(PVA)(购于Sigma-Aldrich,360627)对显色体系稳定性的影响。实验结果如图4所示,随着保存时间的延长,该显色体系的活性均降低;在4℃保存条件下,体系中添加海藻糖的稳定效果优于聚乙烯醇;但在-20℃保存条件下,体系中添加聚乙烯醇的稳定效果优于海藻糖。因此,可根据不同的保存条件,选择不同的添加保护剂以延长体系的保存时间。The non-cellular color-developing system contains a variety of enzyme components. After being placed at 4°C or -20°C for 1 week, the activity decreases significantly. As a new type of biomolecular protective agent, trehalose has been extensively studied and is often used as a protein stabilizer; there are also reports in the literature that polyvinyl alcohol is often used as an additive to maintain the activity of enzymes in the reaction system. In order to improve the stability of the color-developing system, trehalose (purchased from Beijing Probosin Biotechnology Co., Ltd., CAS#99-20-7) and polyvinyl alcohol (PVA) (purchased from Sigma-Aldrich, 360627) influence on the stability of the color-developing system. The experimental results are shown in Figure 4. As the storage time increases, the activity of the color-developing system decreases; under the storage condition of 4℃, the stabilization effect of adding trehalose to the system is better than that of polyvinyl alcohol; but at -20℃ Under storage conditions, the stabilizing effect of adding polyvinyl alcohol to the system is better than that of trehalose. Therefore, according to different storage conditions, different protective agents can be selected to extend the storage time of the system.

实施例5非细胞显色体系在病原微生物检测中的应用Example 5 Application of the non-cellular chromogenic system in the detection of pathogenic microorganisms

本实施例应用于RNA检测的Toehold-Switch开关,检测目标是GII.4型诺如病毒,针对此靶标设计Toehold-Switch元件,结合非细胞显色体系,通过体系颜色的变化判断检测靶标的存在情况。This embodiment is applied to the Toehold-Switch switch for RNA detection. The detection target is Norovirus type GII.4. The Toehold-Switch element is designed for this target, combined with the non-cellular color-developing system, and the presence of the detection target is judged by the change of the system color. Happening.

将实验室筛选得到的针对GII.4型诺如病毒、GII.17型诺如病毒和人冠状病毒的Toehold-Switch元件,以及文献报道的寨卡病毒Toehold-Switch元件等应用上述非细胞体外显色体系,通过是否显色来判定体系中检测目标的有无。按照表 1和2配制非细胞显色体系,质粒为针对各检测靶标的Toehold-Switch元件质粒,30℃条件下与不同靶标的Trigger质粒作用1h后,观察体系颜色变化情况并测定OD570,结果如图5所示。结果显示:当体系中无GII.4型诺如病毒靶标Trigger质粒时,体系颜色没有变化,显示浅黄色,OD值较低;当体系中存在GII.4型诺如病毒靶标Trigger质粒后,体系颜色发生变化,由浅黄色变为紫色,OD570值升高。The Toehold-Switch element for Norovirus GII.4, Norovirus GII.17, and human coronavirus, as well as the Toehold-Switch element for Zika virus reported in the literature, etc., obtained by laboratory screening, were applied to the above non-cellular in vitro display. The color system determines the presence or absence of the detection target in the system by color development. Prepare a cell-free coloring system according to Tables 1 and 2. The plasmid is the Toehold-Switch element plasmid for each detection target. After interacting with Trigger plasmids of different targets at 30°C for 1 hour, observe the color change of the system and determine the OD570. The results are as follows Shown in Figure 5. The results show that when there is no GII.4 Norovirus target Trigger plasmid in the system, the system color does not change, showing light yellow, and the OD value is low; when there is GII.4 Norovirus target Trigger plasmid in the system, the system The color changes from light yellow to purple, and the OD570 value increases.

同理,本实施例结合Toehold-Switch开关,检测目标是金黄色葡萄球菌,针对此靶标设计Toehold-Switch元件,结合非细胞显色体系,通过体系颜色的变化判断检测靶标的存在情况。In the same way, this embodiment combines the Toehold-Switch switch, the detection target is Staphylococcus aureus, the Toehold-Switch element is designed for this target, combined with the non-cellular color-developing system, and the existence of the detection target is judged by the color change of the system.

将实验室筛选的得到的针对金黄色葡萄球菌、单增李斯特菌、沙门氏菌和副溶血弧菌的Toehold-Switch元件等应用于上述非细胞体外显色体系,通过是否显色来判定体系中检测目标的有无。按照表1和2配制非细胞显色体系,质粒为针对各检测靶标的Toehold-Switch元件质粒,30℃条件下与不同靶标的Trigger质粒作用0.7h后,观察体系颜色变化情况并测定OD570,结果如图6所示。结果显示:当体系中无金黄色葡萄球菌靶标Trigger质粒时,体系颜色没有变化,显示浅黄色,OD值较低;当体系中存在金黄色葡萄球菌靶标Trigger时,体系颜色发生变化,由浅黄色变为紫色,OD570值升高。The Toehold-Switch elements for Staphylococcus aureus, Listeria monocytogenes, Salmonella and Vibrio parahaemolyticus, etc. obtained by laboratory screening are applied to the above-mentioned non-cellular in vitro color development system, and the detection in the system is determined by color development. The presence or absence of goals. Prepare the non-cellular color system according to Table 1 and 2. The plasmid is the Toehold-Switch element plasmid for each detection target. After interacting with the Trigger plasmid of different targets at 30℃ for 0.7h, observe the color change of the system and measure the OD570. The result As shown in Figure 6. The results show that when there is no Staphylococcus aureus target Trigger plasmid in the system, the color of the system does not change, showing light yellow, and the OD value is low; when there is a Staphylococcus aureus target Trigger in the system, the system color changes from light yellow It turns purple and the OD570 value increases.

综上,我们建立了一种可视化的微量非细胞体外显色体系,该显色体系可应用于病原微生物的检测,当体系中出现检测目标时,体系颜色由浅黄色变为紫色,肉眼即可判断检测目标的有无。In summary, we have established a visual micro-acellular in vitro color-developing system, which can be applied to the detection of pathogenic microorganisms. When the detection target appears in the system, the color of the system changes from light yellow to purple, which can be done by the naked eye. Determine the presence or absence of detection targets.

上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited by the above-mentioned embodiments, and any other changes, modifications, substitutions, combinations, etc. made without departing from the spirit and principle of the present invention Simplified, all should be equivalent replacement methods, and they are all included in the protection scope of the present invention.

Claims (10)

一种可视化的非细胞体外显色体系的制备方法,其特征在于,包括如下步骤:A method for preparing a visual acellular in vitro color-developing system, which is characterized in that it comprises the following steps: (1)工程菌的制备:(1) Preparation of engineering bacteria: 利用Red重组法敲除大肠杆菌菌株中β-半乳糖苷酶基因,获得工程菌;Using Red recombination method to knock out the β-galactosidase gene in E. coli strains to obtain engineered bacteria; (2)工程菌裂解液的制备:(2) Preparation of engineered bacteria lysate: 测定上述工程菌的生长曲线,制备工程菌裂解液;Determine the growth curve of the above-mentioned engineered bacteria, and prepare the engineered bacteria lysate; (3)显色体系的配制:(3) Preparation of color rendering system: 配制显色体系,包括工程菌裂解液、能量供应体系、氨基酸混合液和其他蛋白质合成所需的底物混合液;所述能量供应体系含磷酸烯醇式丙酮酸。A color-developing system is prepared, including an engineered bacteria lysate, an energy supply system, an amino acid mixture and other substrate mixtures required for protein synthesis; the energy supply system contains phosphoenolpyruvate. 根据权利要求1所述的制备方法,其特征在于,所述能量供应体系的浓度为20~28mM;所述氨基酸混合液的浓度为40~60mM。The preparation method according to claim 1, wherein the concentration of the energy supply system is 20-28 mM; the concentration of the amino acid mixture is 40-60 mM. 根据权利要求1所述的制备方法,其特征在于,所述大肠杆菌菌株为BL21(DE3);所述工程菌裂解液为敲除β-半乳糖苷酶基因的BL21(DE3)裂解液,即BL21(DE3)ΔlacZ裂解液,浓度为20~30%。The preparation method according to claim 1, wherein the E. coli strain is BL21(DE3); the engineered bacteria lysate is BL21(DE3) lysate with β-galactosidase gene knocked out, namely BL21(DE3)ΔlacZ lysate, the concentration is 20-30%. 根据权利要求1所述的制备方法,其特征在于,所述氨基酸混合液为用亮氨酸、甲硫氨酸、缬氨酸、赖氨酸、苯丙氨酸、色氨酸、苏氨酸、甘氨酸、精氨酸、组氨酸、丙氨酸、天冬氨酸、天冬酰胺、异亮氨酸、脯氨酸、酪氨酸、丝氨酸、半胱氨酸、谷氨酸和谷氨酰胺加入水配成的等摩尔浓度的混合液。The preparation method according to claim 1, wherein the amino acid mixture is made of leucine, methionine, valine, lysine, phenylalanine, tryptophan, and threonine. , Glycine, arginine, histidine, alanine, aspartic acid, asparagine, isoleucine, proline, tyrosine, serine, cysteine, glutamic acid and glutamine A mixture of equimolar concentration prepared by adding amide to water. 根据权利要求1~4任意一项所述的制备方法,其特征在于,所述其他蛋白质合成所需的底物混合液为醋酸镁、谷氨酸钾、醋酸铵、HEPES-KOH、tRNA、叶酸、二硫苏糖醇、腐胺、亚精胺、草酸、ATP、CTP、UTP、GTP、PEG8000、RNA酶抑制剂和氯酚红-β-D-半乳吡喃糖苷。The preparation method according to any one of claims 1 to 4, wherein the substrate mixture required for the synthesis of other proteins is magnesium acetate, potassium glutamate, ammonium acetate, HEPES-KOH, tRNA, folic acid , Dithiothreitol, putrescine, spermidine, oxalic acid, ATP, CTP, UTP, GTP, PEG8000, RNase inhibitor and chlorophenol red-β-D-galactopyranoside. 根据权利要求5所述的制备方法,其特征在于,所述显色体系中还添加海藻糖或聚乙烯醇作为保护剂。The preparation method according to claim 5, characterized in that trehalose or polyvinyl alcohol is added as a protective agent in the color-developing system. 根据权利要求6所述的制备方法,其特征在于,所述海藻糖的浓度为0.2~0.6M,聚乙烯醇的浓度为5%~10%。The preparation method according to claim 6, wherein the concentration of the trehalose is 0.2-0.6M, and the concentration of the polyvinyl alcohol is 5%-10%. 权利要求1~7任意一项所述方法制备的可视化的非细胞体外显色体系。A visualized non-cellular in vitro color development system prepared by the method of any one of claims 1-7. 权利要求8所述的可视化的非细胞体外显色体系在病原微生物检测中的应用,其特征在于,设计针对病原微生物检测靶标的Toehold-Switch元件质粒,该质粒5’端部分含有与检测靶标特异结合序列,3’端含有β-半乳糖苷酶基因,将上述质粒和待检样品加入非细胞体外显色体系中,静置反应,通过显色情况来判定体系中检测目标的有无,当呈现黄色时,体系不存在相应检测靶标,当呈现紫色时,体系存在相应检测靶标。The application of the visualized non-cellular in vitro chromogenic system in the detection of pathogenic microorganisms according to claim 8, characterized in that the Toehold-Switch element plasmid for the detection target of pathogenic microorganisms is designed, and the 5'end of the plasmid contains the specificity of the detection target. The binding sequence contains the β-galactosidase gene at the 3'end. The above plasmid and the sample to be tested are added to the non-cellular in vitro color-developing system, and the reaction is allowed to stand still. The color development is used to determine the presence or absence of the detection target in the system. When it is yellow, there is no corresponding detection target in the system, and when it is purple, there is a corresponding detection target in the system. 根据权利要求9所述的应用,其特征在于,所述反应温度为30±5℃,静置时间为20~60min。The application according to claim 9, characterized in that the reaction temperature is 30±5°C, and the standing time is 20-60 min.
PCT/CN2020/122343 2019-11-20 2020-10-21 Visualized non-cell in vitro color development system, and preparation method therefor and use thereof Ceased WO2021098436A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911142081.8 2019-11-20
CN201911142081.8A CN110938644A (en) 2019-11-20 2019-11-20 Visual acellular in-vitro color development system and preparation method and application thereof

Publications (1)

Publication Number Publication Date
WO2021098436A1 true WO2021098436A1 (en) 2021-05-27

Family

ID=69907046

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/122343 Ceased WO2021098436A1 (en) 2019-11-20 2020-10-21 Visualized non-cell in vitro color development system, and preparation method therefor and use thereof

Country Status (2)

Country Link
CN (1) CN110938644A (en)
WO (1) WO2021098436A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110938644A (en) * 2019-11-20 2020-03-31 华南理工大学 Visual acellular in-vitro color development system and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1582582A1 (en) * 2002-11-28 2005-10-05 Riken CELL EXTRACT OF i ESCHERICHIA COLI /i HAVING MUTATION IN S12 RIBOSOMAL PROTEIN AND PROCESS FOR PRODUCING PROTEIN IN CELL-FREE SYSTEM USING THE SAME
EP1655375A1 (en) * 2003-05-22 2006-05-10 Riken Process for producing extract for cell-free protein synthesis and cell extract produced thereby
CN107043756A (en) * 2016-12-30 2017-08-15 武汉金开瑞生物工程有限公司 A kind of method that skeletal muscle receptor tyrosine kinase is prepared by cell free, protein synthesizing system
WO2018159647A1 (en) * 2017-02-28 2018-09-07 Spiber株式会社 Reaction mixture for cell-free protein synthesis, cell-free protein synthesis method in which same is used, and kit for cell-free protein synthesis
CN110938644A (en) * 2019-11-20 2020-03-31 华南理工大学 Visual acellular in-vitro color development system and preparation method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1582582A1 (en) * 2002-11-28 2005-10-05 Riken CELL EXTRACT OF i ESCHERICHIA COLI /i HAVING MUTATION IN S12 RIBOSOMAL PROTEIN AND PROCESS FOR PRODUCING PROTEIN IN CELL-FREE SYSTEM USING THE SAME
EP1655375A1 (en) * 2003-05-22 2006-05-10 Riken Process for producing extract for cell-free protein synthesis and cell extract produced thereby
CN107043756A (en) * 2016-12-30 2017-08-15 武汉金开瑞生物工程有限公司 A kind of method that skeletal muscle receptor tyrosine kinase is prepared by cell free, protein synthesizing system
WO2018159647A1 (en) * 2017-02-28 2018-09-07 Spiber株式会社 Reaction mixture for cell-free protein synthesis, cell-free protein synthesis method in which same is used, and kit for cell-free protein synthesis
CN110938644A (en) * 2019-11-20 2020-03-31 华南理工大学 Visual acellular in-vitro color development system and preparation method and application thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ANDRIY DIDOVYK ET AL.: "Rapid and Scalable Preparation of Bacterial Lysates for Cell-Free Gene Expression", ACS SYNTH BIOL, vol. 6, no. 12, 21 August 2017 (2017-08-21), ISSN: 2161-5063 *
CHEN HAI-QIN, XU ZHI-NAN , WANG CHENG , LIAO YU-HUA , CEN PEI-LIN: "Preliminary Study on Preparation of E.coli Cell-Free System for Protein Expression", JOURNAL OF ZHEJIANG UNIVERSITY(ENGINEERING SCIENCE), vol. 41, no. 5, 15 May 2007 (2007-05-15), CN, pages 834 - 847, XP055814118, ISSN: 1008-973X *
DIDOVYK ANDRIY, TONOOKA TAISHI, TSIMRING LEV, HASTY JEFF: "Rapid and Scalable Preparation of Bacterial Lysates for Cell-Free Gene Expression", ACS SYNTHETIC BIOLOGY, vol. 6, no. 12, 10 August 2017 (2017-08-10), pages 2198 - 2208, XP055814048, ISSN: 2161-5063, DOI: 10.1021/acssynbio.7b00253 *
DUYEN TRAN THI MY; MATSUURA HIDEYUKI; UJIIE KAZUKI; MURAOKA MISA; HARADA KAZUO; HIRATA KAZUMASA: "Paper-based colorimetric biosensor for antibiotics inhibiting bacterial protein synthesis", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 123, no. 1, 31 January 2017 (2017-01-31), pages 96 - 100, XP029862402, ISSN: 1389-1723, DOI: 10.1016/j.jbiosc.2016.07.015 *
MICHAEL C. JEWETT, JAMES R. SWARTZ: "Mimicking the Escherichia coli cytoplasmic environment activates long‐lived and efficient cell‐free protein synthesis", BIOTECHNOLOGY AND BIOENGINEERING, vol. 86, no. 1, 5 April 2004 (2004-04-05), pages 19 - 16, XP055814074, ISSN: 0006-3592, DOI: 10.1002/bit.20026 *
PARDEE KEITH; GREEN ALEXANDER A.; FERRANTE TOM; CAMERON D. EWEN; DALEYKEYSER AJAY; YIN PENG; COLLINS JAMES J.: "Paper-Based Synthetic Gene Networks", CELL, vol. 159, no. 4, 6 November 2014 (2014-11-06), pages 940 - 954, XP029095127, ISSN: 0092-8674, DOI: 10.1016/j.cell.2014.10.004 *
TADANORI KAMEYAMA , G DAVID NOVELLI: "The synthesis of beta-galactosidase by a cell-free preparation from Escherichia coli", PNAS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 48, no. 4, 15 April 1962 (1962-04-15), pages 659 - 666, XP055814086, ISSN: 1091-6490, DOI: 10.1073/pnas.48.4.659 *

Also Published As

Publication number Publication date
CN110938644A (en) 2020-03-31

Similar Documents

Publication Publication Date Title
Taylor et al. Optimizing expression and solubility of proteins in E. coli using modified media and induction parameters
Vara et al. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance
Allers et al. Improved strains and plasmid vectors for conditional overexpression of His-tagged proteins in Haloferax volcanii
Michel-Reydellet et al. Amino acid stabilization for cell-free protein synthesis by modification of the Escherichia coli genome
Sun et al. A simple and low-cost paper-based colorimetric method for detecting and distinguishing the GII. 4 and GII. 17 genotypes of norovirus
Barthel et al. ATPase-defective derivatives of Escherichia coli DnaK that behave differently with respect to ATP-induced conformational change and peptide release
US20220017977A1 (en) Analytes' detection using regulated in vitro transcription
CN102191213B (en) Gene encoding of firefly luciferase, its preparation method and application
US20230212592A1 (en) Riboswitch modules and methods for controlling eukaryotic protein translation
US20060084136A1 (en) Production of fusion proteins by cell-free protein synthesis
WO2021098436A1 (en) Visualized non-cell in vitro color development system, and preparation method therefor and use thereof
US20210147855A1 (en) Optogenetic circuits for controlling chemical and protein production in escherichia coli
WO2021175230A1 (en) Separated cas13 protein
WO2019061381A1 (en) Class of arsenite inhibitory factor reporter gene plasmids, construction method therefor and application thereof
US20140296172A1 (en) Method for screening compounds comprising the use of picornavirus protease 2A
Tomasi et al. A tRNA-acetylating toxin and detoxifying enzyme in Mycobacterium tuberculosis
CN114634958B (en) Method for inserting unnatural amino acids using a cell-free protein synthesis system
CN106480181A (en) For detecting LAMP primer group and its method for transgene component CaMV35S
CN114854694A (en) A luciferase complementation system for high-throughput screening of new crown drugs and its construction method and application
WO2017064718A1 (en) Methods and kits for determining deacylase activity
Foo et al. A temperature sensitive mutant screen reveals translational stress-induced cell cycle regulation in a thermophilic archaeon
CN106591347B (en) A kind of expression system comprising phage lysozyme and its utilization
Li et al. The DEAD-box RNA helicase CrhB exhibits pleiotropic functions in the cyanobacterium Anabaena PCC 7120
Li et al. Identification and characterization of the TetR family transcriptional regulator NffT in Rhizobium johnstonii
Jones Cell-free protein synthesis of secondary metabolite ribosomal peptides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20888904

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20888904

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 10/11/2022)

122 Ep: pct application non-entry in european phase

Ref document number: 20888904

Country of ref document: EP

Kind code of ref document: A1